iRadimed Corporation (IRMD) To Go Ex-Dividend on December 17th

iRadimed Corporation (NASDAQ:IRMD) declared a special dividend on Friday, December 5th. Shareholders of record on Wednesday, December 17th will be given a dividend of 0.50 per share by the medical equipment provider on Tuesday, December 30th. The ex-dividend date of this dividend is Wednesday, December 17th.

iRadimed has a dividend payout ratio of 34.2% indicating that its dividend is sufficiently covered by earnings. Analysts expect iRadimed to earn $2.00 per share next year, which means the company should continue to be able to cover its $0.68 annual dividend with an expected future payout ratio of 34.0%.

iRadimed Trading Down 1.2%

NASDAQ:IRMD opened at $96.23 on Monday. The company has a market capitalization of $1.22 billion, a P/E ratio of 58.32 and a beta of 1.06. iRadimed has a 12 month low of $47.48 and a 12 month high of $98.44. The firm has a fifty day simple moving average of $84.16 and a 200-day simple moving average of $71.74.

iRadimed (NASDAQ:IRMD) last issued its earnings results on Monday, November 3rd. The medical equipment provider reported $0.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.04. iRadimed had a return on equity of 22.93% and a net margin of 26.31%.The company had revenue of $21.20 million during the quarter, compared to analyst estimates of $20.50 million. iRadimed has set its Q4 2025 guidance at 0.470-0.510 EPS and its FY 2025 guidance at 1.840-1.880 EPS. Equities analysts forecast that iRadimed will post 1.66 EPS for the current year.

Insider Buying and Selling

In other news, CFO John Glenn sold 15,000 shares of iRadimed stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $97.29, for a total transaction of $1,459,350.00. Following the completion of the transaction, the chief financial officer directly owned 7,362 shares of the company’s stock, valued at $716,248.98. The trade was a 67.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Roger E. Susi sold 5,000 shares of the business’s stock in a transaction on Monday, December 8th. The shares were sold at an average price of $95.43, for a total transaction of $477,150.00. Following the completion of the transaction, the chief executive officer owned 2,297,500 shares of the company’s stock, valued at approximately $219,250,425. This represents a 0.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 70,000 shares of company stock worth $5,777,150 in the last ninety days. Corporate insiders own 36.80% of the company’s stock.

Institutional Investors Weigh In On iRadimed

Hedge funds have recently modified their holdings of the company. CWM LLC increased its stake in shares of iRadimed by 62.2% in the 3rd quarter. CWM LLC now owns 550 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 211 shares in the last quarter. Quarry LP acquired a new position in iRadimed in the 3rd quarter valued at $40,000. State of Alaska Department of Revenue purchased a new position in shares of iRadimed in the third quarter worth about $47,000. Tower Research Capital LLC TRC boosted its holdings in shares of iRadimed by 191.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 754 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 495 shares during the last quarter. Finally, Spire Wealth Management purchased a new stake in shares of iRadimed in the second quarter valued at approximately $60,000. 92.34% of the stock is owned by hedge funds and other institutional investors.

iRadimed Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.